Homozygous deletion of Uhrf1 with concomitant activation of the Kras G12D allele and loss of Trp53 led to a significant decrease in tumor formation compared to Uhrf1 wild-type mice (Fig. 6a, c). This evidence concerns the gene KRAS and neoplasm.